The prognostic impact of prior low grade histology in patients with anaplastic gliomas: A case-control study

Neurology

Volumn 47, Issue 3, 1996, Pages 684-690

  Dropcho, Edward J ^a   Soong, Seng Jaw ^b  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; DIAZIQUONE; HYDROXYUREA; LOMUSTINE; MERCAPTOPURINE; NITROSOUREA; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; CASE CONTROL STUDY; CENTRAL NERVOUS SYSTEM TUMOR; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029843049     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.3.684     Document Type: Article

References (24)

1. Muller W, Afra D, Schröder R. Supratentorial recurrences of gliomas: morphological studies in relation to time intervals with astrocytomas. Acta Neurochir (Wien) 1977;37:75-91.
2. Afra D, Muller W, Benoist G, Schröder R. Supratentorial recurrences of gliomas: results of reoperations on astrocytomas and oligodendrogliomas. Acta Neurochir (Wien) 1978;43:217-227.
3. Laws ER, Taylor WF, Clifton MB, Okazaki H. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 1984;61:665-673.
4. Vertosick FT, Selker RG, Arena VC. Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography. Neurosurgery 1991;28:496-501.
5. Scherer HJ. Cerebral astrocytomas and their derivatives. Am J Cancer 1940;40:159-198.
6. Burger PC, Kleihues P. Cytologie composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer 1989;63:2014-2023.
7. Winger MJ, Macdonald DR, Cairncross JG. Supratentorial anaplastic gliomas: the prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 1989;71:487-493.
8. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumors. Brain Pathol 1993;3:255-268.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
10. Mantel N. Evaluation of survival data and two new rank order statistics arising from its consideration. Cancer Chemother Rep 1966;50:163-170.
11. Shaw EG, Scheithauer BW, Gilbertson DT, et al. Postoperative radiotherapy of supratentorial low-grade gliomas. Int J Radiât Oncol Biol Phys 1989; 16:663-668.
12. Shaw EG, Scheithauer B, O'Fallon J. Astrocytomas, oligoastrocytomas, and oligodendrogliomas: a comparative study [abstract]. Neurology 1992;42(suppl 3):342.
13. Whitton AC, Bloom HJ. Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases. Int J Radiât Oncol Biol Phys 1990;18:783-786.
14. Byar DP, Green SB, Strike TA. Prognostic factors for malignant gliomas. In: Walker MD, ed. Oncology of the nervous system. Boston: Martinus Nijhoff, 1983:379-395.
15. Wood JR, Green SB, Shapiro WR. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 1988;6:338-343.
16. Simpson JR, Horton J, Scott C, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiât Oncol Biol Phys 1993;26:239-244.
17. Nazzaro JM, Neuwelt EA. The role of surgery in the manage- ment of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 1990;73:331-344.
18. Walker MD, Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. J Neurosurg 1978;49:333-343.
19. Walker MD, Green SB, Byar DP, et al. Randomized comparison of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. New Engl J Med 1980;303: 1323-1329.
20. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993;3: 19-26.
21. Chozick BS, Weicker E, Pezzullo JC, et al. Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternate pathways of tumorigenesis. Cancer 1994;73:406-415.
22. Lang FF, Miller DC, Koslow M, Newcomb EW. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994; 81:427-436.
23. Bello MJ, Leone PE, Nebreda P, et al. Allelic status of chromosome 1 in neoplasms of the nervous system. Cancer Genet Cytogenet 1995;83:160-164.
24. von Deimling A, Nagel J, Bender B, et al. Deletion mapping of chromosome 19 in human gliomas. Int J Cancer 1994;57:676-680.